GERN Stock Analysis: Buy, Sell, or Hold?
GERN - Geron Corp
$1.41
0.05 (4.07%)
▲
5d:
+19.07%
30d:
+9.77%
90d:
-6.95%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Smart Money Accumulation
None View Scanner →
Strength: 7.6/10
Get Alerted When GERN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: GERN is 9.8% above its trading range ($1.28). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: GERN is 9.8% above its trading range ($1.28). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: GERN is currently trading at $1.41, which is considered extended relative to its 30-day fair value range of $1.15 to $1.28. The stock's valuation (Forward PE: 20.8) is in line with its historical norms (20.3). At these levels, the market is pricing in 0.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, GERN is in a downtrend. The price is approaching resistance at $1.37. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.1% recently.
Market Sentiment: GERN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.40 (+151.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GERN is in a downtrend. The price is approaching resistance at $1.37. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.1% recently.
Market Sentiment: GERN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.40 (+151.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.15 -
$1.28
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
62.9%
Protect Your Profits
Holding GERN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+9.8% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.1%)
- BULLISH: Trading 151.9% below Wall St target ($3.40)
- NEUTRAL: Market pricing in 0.7% annual earnings growth - fairly valued
- CAUTION: Extended 9.8% above its trading range - wait for pullback
Trading Range Analysis
30-Day Trading Range
$1.15 -
$1.28
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.08
Resistance Level
$1.37
Current Trend
Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
20.77
Wall Street Target
$3.40
(+151.9%)
Revenue Growth (YoY)
30.9%
Profit Margin
-34.3%
Valuation Premium vs History
+0.7% premium
PE vs Historical
20.8 vs 20.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.7%
(market-implied from PE analysis)
1-Year Target
$1.36
(+1%)
2-Year Target
$1.37
(+1%)
3-Year Target
$1.38
(+2%)
3-Yr Target (if PE normalizes)
(PE: 21→20)
PE COMPRESSION
$1.35
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: June 24, 2026 11:28 AM ET
Data refreshes hourly during market hours. Next update: 12:28 PM
Data refreshes hourly during market hours. Next update: 12:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GERN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 56 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 57 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 67 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
Advanced GERN Option Strategies
Professional options setups generated by AI based on today's GERN price and gamma walls.
